Smith & Nephew SNATS Total Assets 2006-2018 | SNN

Smith & Nephew SNATS total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Smith & Nephew SNATS total assets for the quarter ending December 31, 2018 were $7.866B, a 9.02% increase year-over-year.
  • Smith & Nephew SNATS total assets for 2018 were $8.059B, a 2.45% increase from 2017.
  • Smith & Nephew SNATS total assets for 2017 were $7.866B, a 7.11% increase from 2016.
  • Smith & Nephew SNATS total assets for 2016 were $7.344B, a 2.47% increase from 2015.
Smith & Nephew SNATS Annual Total Assets
(Millions of US $)
2018 $8,059
2017 $7,866
2016 $7,344
2015 $7,167
2014 $7,306
2013 $5,819
2012 $5,642
2011 $4,747
2010 $4,733
2009 $4,565
2008 $4,508
2007 $4,450
2006 $3,231
2005 $3,194
Smith & Nephew SNATS Quarterly Total Assets
(Millions of US $)
Q4 2017 $7,866
Q2 2017 $7,439
Q4 2016 $7,344
Q4 2015 $7,167
Q2 2015 $7,215
Q4 2014 $7,306
Q3 2014 $7,650
Q2 2014 $7,742
Q1 2014 $5,940
Q4 2013 $5,819
Q3 2013 $5,567
Q2 2013 $5,452
Q1 2013 $5,465
Q4 2012 $5,642
Q3 2012 $4,997
Q2 2012 $4,812
Q1 2012 $4,884
Q4 2011 $4,747
Q3 2011 $4,821
Q2 2011 $4,909
Q1 2011 $4,790
Q4 2010 $4,733
Q3 2010 $4,878
Q2 2010 $4,583
Q1 2010 $4,535
Q4 2009 $4,565
Q3 2009 $4,627
Q2 2009 $4,517
Q1 2009 $4,306
Q4 2008 $4,508
Q3 2008 $4,525
Q2 2008 $4,709
Q1 2008 $4,671
Q4 2007 $4,450
Q3 2007 $4,276
Q2 2007 $4,233
Q1 2007 $3,217
Q4 2006 $3,231
Q3 2006 $3,202
Q2 2006 $3,163
Q1 2006 $3,099
Q4 2005 $3,194
Q3 2005 $2,978
Q2 2005 $3,088
Q1 2005 $3,026
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.634B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.623B 27.80
Medtronic (MDT) Ireland $123.520B 18.06
Stryker (SYK) United States $73.875B 27.09
Boston Scientific (BSX) United States $52.874B 25.78
Baxter (BAX) United States $40.209B 25.72
Zimmer Biomet Holdings (ZBH) United States $26.486B 16.96
Canopy Growth (CGC) Canada $15.407B 0.00
ResMed (RMD) United States $14.469B 27.44
Aurora Cannabis (ACB) Canada $9.687B 68.36
Bio-Rad Laboratories (BIO) United States $9.455B 53.94
Hill-Rom Holdings (HRC) United States $7.140B 22.08
Perrigo (PRGO) Ireland $6.601B 10.70
Insulet (PODD) United States $6.039B 2037.40
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.841B 30.14
Haemonetics (HAE) United States $4.496B 39.88
Hutchison China MediTech (HCM) China $3.961B 0.00
Agios Pharmaceuticals (AGIO) United States $3.830B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.927B 25.53
Quidel (QDEL) United States $2.672B 24.11
Aphria (APHA) $2.518B 111.78
National Vision Holdings (EYE) United States $2.327B 45.77
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.402B 1006.25
Phibro Animal Health (PAHC) United States $1.308B 18.80
VAREX IMAGING (VREX) United States $1.299B 25.44
AtriCure (ATRC) United States $1.104B 0.00
Lantheus Holdings (LNTH) United States $0.968B 26.15
MacroGenics (MGNX) United States $0.967B 0.00
Cerus (CERS) United States $0.885B 0.00
PetIQ (PETQ) United States $0.872B 24.96
Omeros (OMER) United States $0.868B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Meridian Bioscience (VIVO) United States $0.727B 21.67
OraSure Technologies (OSUR) United States $0.713B 31.24
Eagle Pharmaceuticals (EGRX) United States $0.705B 23.99
Evolus (EOLS) United States $0.701B 0.00
TG Therapeutics (TGTX) United States $0.650B 0.00
Surmodics (SRDX) United States $0.618B 89.94
LeMaitre Vascular (LMAT) United States $0.614B 29.21
Quanterix (QTRX) United States $0.551B 0.00
BioLife Solutions (BLFS) United States $0.397B 163.54
Vapotherm (VAPO) United States $0.371B 0.00
Rockwell Medical (RMTI) United States $0.363B 0.00
Insys Therapeutics (INSY) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.30
Owens & Minor (OMI) United States $0.284B 3.94
Bovie Medical (APYX) United States $0.264B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.257B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Zynex (ZYXI) United States $0.143B 15.35
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.117B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 20.01
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Neurotrope (NTRP) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 15.57